Pfizer mulls possible OTC switch for Lipitor

Share this article:

Pfizer is reportedly weighing an attempt at an over-the-counter switch for Lipitor – a move that could help the company recoup some of its losses when the $11 billion drug loses nationwide exclusivity in November. But the reception from analysts has been muted so far. Pfizer is exploring the possibility of a branded generic, as well as an OTC switch, according to several sources.


Share this article:

More in Products

Malnutrition remains issue

Identifying malnutrition in patients upon admission to a hospital is a low-cost way to improve patient outcomes and reduce readmissions, a new report says. Alleviating Hospital-Based Malnutrition: A Baseline Progress Report is an assessment of hospital-based malnutrition released in connection with the first anniversary of ...

Construction Specialties introduces wall and door protection

Construction Specialties introduces wall and door protection

Construction Specialties Inc. (C/S) has debuted a new line of wall and door protection, Acrovyn by Design and Acrovyn Doors by Design. The products embed high-resolution images and logos as ...

BioSensics launches ActivePERS fall detection

BioSensics launches ActivePERS fall detection

BioSensics has introduced ActivePERS, a personal emergency response and telemonitoring solution for seniors.